0001127602-18-036571.txt : 20181218 0001127602-18-036571.hdr.sgml : 20181218 20181218162210 ACCESSION NUMBER: 0001127602-18-036571 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181214 FILED AS OF DATE: 20181218 DATE AS OF CHANGE: 20181218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: APPIO THOMAS CENTRAL INDEX KEY: 0001683323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 181240777 MAIL ADDRESS: STREET 1: 400 SOMERSET CORPORATE BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-12-14 0000885590 Bausch Health Companies Inc. BHC 0001683323 APPIO THOMAS 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 Pres&Co-Head Bausch&Lomb/Int'l Common Stock, No Par Value 2018-12-14 4 P 0 25440 22.9567 A 128922 D Common Stock, No Par Value 2018-12-14 4 A 0 25440 0 A 154362 D The price in Column 4 is a weighted average price. The prices actually paid in this transaction are within the range of $22.94 to $22.96 per share. Upon request by the Commission staff, the Issuer or the reporting person will provide full information regarding the number of Common Shares purchased by the reporting person at each separate price within the range set forth in this footnote. Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported above (the "Purchased Shares"), pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant ("MRSU Grant Date"), subject to the Reporting Person's continued service (except in limited circumstances). /s/ Kirsten O'Donnell, attorney-in-fact for Thomas Appio 2018-12-18